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In developing limb skin, peripheral nerves provide
a spatial template that controls the branching pattern
and differentiation of arteries. Our previous studies
indicate that nerve-derived VEGF-A is required for
arterial differentiation but not for nerve-vessel
alignment. In this study, we demonstrate that
nerve-vessel alignment depends on the activity of
Cxcl12-Cxcr4 chemokine signaling. Genetic inactiva-
tion of Cxcl12-Cxcr4 signaling perturbs nerve-vessel
alignment and abolishes arteriogenesis. Further
in vitro assays allow us to uncouple nerve-vessel
alignment and arteriogenesis, revealing that nerve-
derived Cxcl12 stimulates endothelial cell migration,
whereas nerve-derived VEGF-A is responsible for
arterial differentiation. Thesefindingssuggest a coor-
dinated sequential action in which nerve Cxcl12
functions over a distance to recruit vessels to align
with nerves, and subsequent arterial differentiation
presumably requires a local action of nerve VEGF-A
in the nerve-associated vessels.
INTRODUCTION
The vascular system, which is a vast network of arteries, veins,
and capillaries, is crucial for organ development during embryo-
genesis as well as for organmaintenance and reproductive func-
tion in the adult. Despite the significance of the vascular system,
the process by which it adopts a particular blood vessel branch-
ing pattern is poorly understood. The patterning is thought to
occur by remodeling a pre-existing primary capillary network
into a highly branched hierarchical vascular tree. It has been sug-
gested that environmental factors may function as guidance
cues to form a tissue-specific vascular pattern. The loss of guid-
ance cues has been shown to lead to abnormal vascularization,
which contributes to a number of pathologically identifiableDevelopmconditions (reviewed in Dorrell and Friedlander, 2006). Although
guidance molecules capable of inducing endothelial cell sprout-
ing have been identified (reviewed in Adams and Eichmann,
2010), the source tissue or cells for these guidance molecules,
however, is less clear. In addition, the role of nonvascular tissues
in patterning the emerging vascular network remains largely
unknown.
To study the elaborate and intricate processes of vascular
branching, a directly observable vascular network with an
anatomically recognizable pattern is an ideal model. Thus, we
developed amodel system using the embryonic limb skin vascu-
lature. Embryonic limb skin has a highly stereotypic and recog-
nizable vascular branching (Mukouyama et al., 2002). During
angiogenesis in the embryonic limb skin, the arterial branching
pattern coincides with the branching pattern of pre-established
sensory nerves. At embryonic day (E)13.5, there is no association
between sensory nerves and blood vessels and no detectable
arterial marker expression in the capillary plexus. By E14.5,
vascular remodeling occurs and these remodeled vessels asso-
ciate with sensory nerves. At this stage, some nerve-associated
vessels express arterial markers such as ephrinB2 and neuro-
pilin 1 (Nrp1), but the other nerve-associated smaller-diameter
vessels do not yet express them. By E15.5, most nerve-associ-
ated vessels express arterial markers. Extensive time-course
analysis reveals that arterial differentiation is immediately pre-
ceded by nerve-vessel alignment (Mukouyama et al., 2002). In
Ngn1/; Ngn2/ double homozygous mutant embryos lacking
peripheral axons and Schwann cells in the embryonic skin, the
primitive capillary plexus forms normally but proper arterial
differentiation fails to occur. Moreover, in Sema3A/ mutants,
where the pattern of sensory nerve branching is disrupted, the
arterial branching pattern still follows the trajectory of the disor-
ganized nerves (Mukouyama et al., 2002). These genetic studies
in mouse embryos suggest that arterial differentiation is depen-
dent on the presence of nerves and that nerves provide
a template that instructively patterns the branching of the
emerging arterial vascular network.
What signals control nerve-vessel alignment and arterial differ-
entiation? Genetic studies in mouse and zebrafish embryos
demonstrated that activation of VEGF-A and Notch signalingental Cell 24, 359–371, February 25, 2013 ª2013 Elsevier Inc. 359
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2002; Mukouyama et al., 2002; Visconti et al., 2002). Inactivation
of nerve-derived Vegf-a or endothelial Nrp1, a coreceptor for
VEGF-A, indeed led to defects in arterial differentiation of limb
skin vasculature (Mukouyama et al., 2005). However, nerve-
vessel alignment was unaffected in these conditional mutants
(Mukouyama et al., 2005). This observation suggests that
unidentified nerve-derived signalsmight govern the nerve-vessel
alignment in the limb skin. It is therefore probable that two
distinct mechanisms exist to control nerve-mediated arterial
branching patterns: one controlling arterial differentiation, and
another for vessel branching and alignment with nerves.
Like VEGF signaling, tyrosine kinase receptor signaling sys-
tems have been implicated in vascular development (reviewed
in Coultas et al., 2005; Risau, 1997). Loss-of-function mutations
in many of the genes encoding these receptors result in embry-
onic lethality due to defects in early vascular development
(reviewed in Argraves and Drake, 2005). This leaves open the
possible contribution of other ligand-receptor signaling path-
ways for vascular branching. Of the potential candidate signals,
we considered the G protein-coupled receptor (GPCR) signaling
pathway, which has diverse functions in vascular development
such as endothelial cell proliferation, migration, and cell death
in a tissue-specific manner. Among the GPCRs it has been
demonstrated that activation of the CXC motif chemokine
receptor Cxcr4 by its soluble ligand Cxcl12 (also known as
SDF1) influences endothelial sprouting in the developing gut
(Tachibana et al., 1998; Ara et al., 2005), kidney (Takabatake
et al., 2009), and retina vasculature (Strasser et al., 2010). In
zebrafish embryos, endoderm-derived Cxcl12 is essential for
complete connection of the developing Cxcr4+ lateral dorsal
aorta, the major arterial vessel in the anterior vasculature (Siek-
mann et al., 2009). Cxcl12 also directs trunk lymphatic network
formation, resulting in a coalignment of lymphatic and blood
vessels (Cha et al., 2012). These observations suggest that
Cxcl12-Cxcr4 signaling may contribute to angiogenic sprouting
from the larger artery and to the linking of adjacent endothelial
cells by guiding filopodium extension. However, the possible
contribution of Cxcl12-Cxcr4 signaling to the formation of
vascular branching patterns via remodeling of a pre-existing
capillary network has not been explored.
In this study, we demonstrate genetic evidence in mice that
Cxcl12-Cxcr4 signaling plays an essential role in nerve-mediated
arterial branching, resulting in nerve-artery alignment in the
limb skin. Peripheral nerves express Cxcl12, whereas its
receptor Cxcr4 is expressed by a subset of endothelial cells
in the capillary network before remodeling. After remodel-
ing, Cxcr4 expression is restricted to larger nerve-associated
arteries. Our in vitro experiments suggest that Cxcl12-Cxcr4
signaling is a major determinant for nerve-mediated endothelial
cell migration but not arterial differentiation. In mutants lacking
Cxcl12, Cxcr4, or endothelial Cxcr4, arteries in the limb skin fail
to properly align with nerves. Taken together with our previous
genetic finding that lack of Schwann cells prevents proper
vascular remodeling and nerve-vessel alignment (Mukouyama
et al., 2002), these data suggest that Cxcl12 is a nerve-derived
vascular patterning signal controlling proper nerve-artery net-
work formation through endothelial Cxcr4 in the developing
limb skin.360 Developmental Cell 24, 359–371, February 25, 2013 ª2013 ElsevRESULTS
Expression of Cxcl12 and Cxcr4 in the Developing Limb
Skin
We first characterized the expression of 24 chemokine ligands
in dorsal root sensory ganglia (DRG) and 17 receptors in
PECAM-1+ limb skin endothelial cells isolated by fluorescence-
activated cell sorting (FACS) using an RT-PCR array method
(data not shown). Among those tested, a semiquantitative RT-
PCR analysis confirmed the expression of Cxcl12, and its recep-
tors Cxcr4 and Cxcr7, at E13.5 and E15.5, the stages at which
vascular remodeling occurs, resulting in nerve-vessel alignment
(Figures S1A and S1B available online). Whole-mount immuno-
histochemical staining was then used to examine the distribution
of these proteins in the limb skin from E13.5 through E15.5.
To detect Cxcl12 expression, we used Cxcl12GFP knockin
embryos expressing GFP from the Cxcl12 locus (Ara et al.,
2005). At E13.5, the expression of Cxcl12 was apparent in all
the nerves in the limb skin, especially in nerve-associated
migrating Schwann cells, which are identified by the glial marker
brain fatty acid-binding protein (BFABP) (Figures 1A and 1C, and
Figures S1E and S1F, open arrows; Kurtz et al., 1994). The
expression persisted at E15.5, after nerve-blood vessel align-
ment had occurred (Figures 1B and 1D, open arrows). If nerve-
derived Cxcl12 plays an instructive role in recruiting arterial
vessels to align with nerves, we might expect that a subset of
vessels would express higher levels of its receptors before the
alignment occurs. In accordance with this prediction, we de-
tected a mosaic distribution of Cxcr4 protein on capillary vessels
near the nerves at E13.5 (Figures 1E and 1G, arrowheads). At this
stage, there was little difference in the expression of the arterial
transcription factors Hey1 and Hey2 mRNAs and the venous
markers EphB4, COUPTFII, and BMX mRNAs between Cxcr4+
and Cxcr4 endothelial cells (Figures S1C and S1D). By E15.5,
however, Cxcr4 expression was restricted only to nerve-associ-
ated arteries (Figures 1F and 1H, arrowheads; Figures S1G and
S1H, arrowheads). Interestingly, Cxcr4 expression was detected
in small-diameter arteries that aligned with the disorganized
nerves in Sema3A/ mutants, suggesting that the pattern of
Cxcr4+ arteries depends on the pattern of nerve branching (Fig-
ures S1I versus S1J, and S1K versus S1L, open arrows and
arrowheads). In contrast, Cxcr7 expression appeared to be
uniformly distributed in the limb skin without any vessel-specific
restriction (data not shown). These results suggest that nerve-
derived Cxcl12 and endothelial Cxcr4 may be responsible for
nerve-vessel alignment in the limb skin.
Failure of Nerve-Vessel Alignment in Cxcl12 and Cxcr4
Homozygous Mutants
To examine the functional role of Cxcl12-Cxcr4 signaling in
nerve-vessel alignment, we carried out a genetic analysis of
nerve-vessel association in Cxcl12/ and Cxcr4/ mutant
embryos. In developing limb skin, peripheral nerves associate
with remodeled vessels (Figures 2A and 2G, open arrows and
arrowheads). In Cxcl12/ and Cxcr4/ mutants, nerve-vessel
alignment was greatly disrupted (Figures 2A versus 2B and 2C,
and 2G versus 2H and 2I, open arrows and arrowheads),
although some vascular remodeling occurred with disorganized
branching patterns (Figures 2B, 2C, 2E, 2F, 2H, 2I, 2K, and 2L,ier Inc.
Figure 1. Complementary Expression of Cxcl12 and Its Receptor
Cxcr4 in Nerves and Vessels in the Developing Limb Skin
Whole-mount immunohistochemical analysis of limb skin from E13.5 and
E15.5 Cxcl12GFP embryos with antibodies to the neuron-specific marker
bIII tubulin (Tuj1) (A and B, blue; E and F, green), the Schwann cell marker
BFABP (A–D, red), the pan-endothelial cell marker PECAM-1 (E–H, blue),
Cxcl12 (Cxcl12GFP) (A–D, green), and Cxcr4 (anti-Cxcr4 antibody from Bio-
trend) (E–H, red) is shown. At E13.5, no association between nerves and
capillary vessels was yet evident (E). BFABP+ migrating Schwann cells in
nerves express Cxcl12 (A and C, open arrows). Cxcr4 expression was de-
tected in a subset of capillary vessels near nerves (E and G, red, arrowheads).
By E15.5, vascular remodeling had occurred, and nerves were associated
with arteries (F). Schwann cells continued to express Cxcl12 (B and D, open
arrows), whereas Cxcr4 expression was restricted to nerve-associated
arteries (F and H, arrowheads).
Scale bars represent 100 mm. See also Figure S1.
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Developmarrowheads). We quantified the amount of nerve-vessel align-
ment by measuring the fractional length of nerves associated
with vessels. Compared to control littermates, a marked re-
duction (60%) of nerve-vessel alignment was observed in
Cxcl12/ and Cxcr4/ mutants (Figure 2M), although there
was no significant difference in vascular density between
these mutants and control littermates (Figure 2N). When tested
for innervation, normal innervation accompanied by BFABP+
migrating Schwann cells was observed in thesemutants (Figures
S2A versus S2B and S2C, S2D versus S2E and S2F, and S2G
versus S2H and S2I, arrows). There was no statistically signifi-
cant difference in the number of BFABP+ Schwann cells between
control littermates and Cxcl12/ or Cxcr4/ mutants (Fig-
ure S2J). Indeed, embryos bearing endothelial cell-specific dele-
tion of Cxcr4 (Tie2-Cre; Cxcr4flox/) exhibited similar defects to
those observed in conventional Cxcl12/ or Cxcr4/ mutants
(Figures S2K versus S2L and S2M versus S2N, open arrows
and arrowheads, and Figure S2O). Of note, the endothelial-
specific Cxcr4 mutants exhibited normal innervation with
BFABP+ Schwann cells as those observed in control littermates
(Figures S2P versus S2Q and S2R versus S2S, arrows, and Fig-
ure S2T). These data suggest that defective nerve-vessel align-
ment is due to lack of Cxcl12-Cxcr4 signaling in endothelial cells.
To rule out the possibility that the observed failure of nerve-
vessel alignment might have been a result of cardiac defects
or vascular failure in major vessels, we examined gross mor-
phology of the null mutants’ heart and trunk vasculature. We
did not observe any morphological change in major vessels of
the forelimb (Figures S3A versus S3B and S3C, arrowheads).
Trunk vasculature, heart endocardium, and myocardial trabecu-
lation appeared unaffected in the mutants at E15.5 (Figures S3D
versus S3E and S3F, H&E staining; Figures S3G versus S3H and
S3I and S3J versus S3K and S3L, arrowheads; Figures S3M
versus S3N and S3O, open arrowheads). Taken together, these
data indicate that the observed failure of nerve-vessel alignment
in the limb skin is not a consequence or a cause of global
vascular or cardiac defects.
Defective Arterial Differentiation and Smooth Muscle
Coverage in Cxcl12 and Cxcr4 Homozygous Mutants
We next examined whether the perturbation in nerve-vessel
alignment is accompaniedbydefective arteriogenesis. Toassess
this, we analyzed the expression of arterial markers Nrp1 and
connexin 40 (Cx40). In control littermates, nerves associated
with small- and middle-diameter branched arterial vessels
(Figures 3A, 3D, 3H, and 3K, arrowheads). Nrp1 expression
was detected both in small- and middle-diameter arteries
(Figures 3A and 3D, arrowheads), whereas Cx40 expression
was relatively specific for middle-diameter arteries (Figures 3H
and 3K, arrowheads). Nerve-associated vessels were covered
byaSMA+ smoothmuscle cells (Figures 3Oand3R, arrowheads).
InCxcl12/ andCxcr4/mutants, the expression of these arte-
rial markers was greatly reduced in small- and middle-diameter
branched vessels (Nrp1: Figures 3D versus 3E and 3F, arrow-
heads, andFigure3G;Cx40: Figures3Kversus3Land3M,arrow-
heads, and Figure 3N). Weak expression of Nrp1 was detected
in some small-diameter branched vessels located in relatively
close proximity to nerves (Figures 3E and 3F, open arrowheads).
Cx40 expression was almost undetectable in middle-diameterental Cell 24, 359–371, February 25, 2013 ª2013 Elsevier Inc. 361
Figure 2. Disruption of Nerve-Vessel Align-
ment in Cxcl12 and Cxcr4 Homozygous
Mutants
(A–L) Whole-mount double immunofluorescence
labeling of limb skin with antibodies to PECAM-1
(A–C and G–I, blue; D–F and J–L, white) and bIII
tubulin (Tuj1) (A–C and G–I, green) in Cxcl12/
mutants (B, E, H, and K),Cxcr4/mutants (C, F, I,
and L), or control littermates (A, D, G, and J)
at E15.5 is shown. Close-up images (G–I and
J–L) show the boxed regions in (A)–(C) and
(D)–(F), respectively. BothCxcl12/ andCxcr4/
mutants exhibited aberrant patterns of remodeled
vessels (B, E, H, and K forCxcl12/mutants; C, F,
I, and L for Cxcr4/ mutants, arrowheads), re-
sulting in disruption of nerve-vessel alignment
(B, C, H, and I, open arrows and arrowheads). Note
that branching patterns of Tuj1+ nerves are not
affected in either homozygous mutant (A–C and
G–I, green). Scale bars represent 100 mm.
(M) Quantification of nerve-vessel alignment as the
percentage of nerve length aligned with vessels
was performed. Cxcl12/ and Cxcr4/ mutants
exhibit defective nerve-vessel alignment. Asterisk
indicates statistically significant difference (p <
0.05) in both mutants compared with control
littermates according to Student’s t test (n = 5 per
genotype; bars represent mean ± SEM).
(N) Quantification of vascular density in Cxcl12/
and Cxcr4/ mutants compared with control
littermates is shown (n = 4 per genotype; bars
represent mean ± SEM). There is no significant
difference in vascular density between Cxcl12/
mutants, Cxcr4/ mutants, and control litter-
mates.
See also Figures S2 and S3.
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reduction of aSMA+ smooth muscle cells associated with
small-diameter branched vessels in Cxcl12/ and Cxcr4/
mutants (Figures 3R versus 3S and 3T, arrowheads; Figure 3U),
although smooth muscle coverage in large-diameter veins
appeared unaffected (Figures 3R versus 3S and 3T, open arrow-
heads). Likewise, in Tie2-Cre; Cxcr4flox/ mutants, we detected
a marked reduction of arterial marker expression (Figures 4C
versus 4D, arrowheads, and Figure 4E) and smooth muscle362 Developmental Cell 24, 359–371, February 25, 2013 ª2013 Elsevier Inc.coverage (Figures 4H versus 4I, arrow-
heads, and Figure 4J). Taken together,
these data indicate that defects in
the nerve-vessel alignment observed
in Cxcl12/ and Cxcr4/ mutants are
accompanied by impaired arterial differ-
entiation and smooth muscle coverage.
We next examined whether Cxcr7,
another high-affinity receptor for Cxcl12,
also has an effect on nerve-vessel align-
ment and arterial differentiation. Early
studies demonstrated that Cxcr7 may
modulate or fine-tune the activation of
Cxcr4 in response to Cxcl12 (Raz and
Mahabaleshwar, 2009). Gross inspection
of limb skin vasculature in Cxcr7/mutants showed that vascular remodeling appeared unaffected
(Figures S4C versus S4D, arrowheads) and most remodeled
vessels aligned with nerves (Figures S4A versus S4B, open
arrows and arrowheads). Innervation accompanied by BFABP+
migrating Schwann cells appeared normal in the mutants
(Figures S4F versus S4G and S4H versus S4I, arrows, and Fig-
ure S4J). However, some smaller vessel branches failed to
associate with nerves (Figures S4B and S4D, arrows and open
arrowheads), demonstrating that Cxcr7/ mutants have less
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(Figure S4E). Because Cxcl12/ or Cxcr4/ mutants display
more severe defect in nerve-vessel alignment than Cxcr7/
mutants, the loss of Cxcl12-Cxcr4 signaling in endothelial cells
primarily influences the fidelity with which remodeled vessel
branches align with nerves. We further examined whether the
loss of Cxcr7 expression affects arterial differentiation and
smooth muscle coverage. No evident attenuation of arterial
marker expression was observed in Cxcr7/ mutants (Figures
S4M versus S4N, arrowheads, and Figure S4O). Smooth muscle
cell coverage of remodeled small-diameter arteries and large-
diameter veins also appeared to be normal in the mutants
(Figures S4R versus S4S, arrowheads, and Figure S4T). Consid-
ering our observation that the defects in nerve-vessel alignment
and arteriogenesis in Cxcl12/ and Cxcr4/ mutants are fully
penetrant, Cxcr7 signalingmay not be required for proper arterial
differentiation and smooth muscle coverage.
Cxcl12-Cxcr4 Signaling Does Not Directly Control
Arterial Differentiation
We next considered whether the loss of Cxcl12-Cxcr4 signaling
perturbs both nerve-vessel association and arterial differentia-
tion. Our previous studies demonstrated that nerve-derived
VEGF-A is required to induce arteriogenesis but not nerve-vessel
alignment (Mukouyama et al., 2005). To examine whether Cxcl12
can induce arterial differentiation with or without the addition of
VEGF-A, we turned to in vitro culture experiments using FACS-
purified endothelial cells. As previously described (Mukouyama
et al., 2002, 2005), we isolated ephrinB2, PECAM-1+ endothe-
lial cells from ephrinB2taulacZ/+ embryos and cultured the cells
in the presence of basic fibroblast growth factor (bFGF) to
support cell survival (Figure 5A). Addition of VEGF-A164 to the
culture media induced expression of ephrinB2-taulacZ (Fig-
ure 5B). In contrast, Cxcl12 alone did not upregulate ephrinB2-
taulacZ expression at any concentration tested (Figure 5B;
100900 ng/ml, data not shown). Furthermore, VEGF-A164
plus Cxcl12 did not lead to arterial differentiation with synergistic
kinetics (Figure 5B). Both factors did not affect cell survival or cell
proliferation (Figures 5C, 5E, and 5G). Thus, these data indicated
that Cxcl12 may not direct arterial differentiation in limb skin.
Because Cxcr4 expression was detected in a subset of endo-
thelial cells in the limb skin vasculature (Figures 1E and 1G,
arrowheads), we sought to further subfractionate ephrinB2,
PECAM-1+ endothelial cells by Cxcr4 expression and examine
whether ephrinB2, PECAM-1+, Cxcr4+ endothelial cells might
upregulate arterial marker expression in response to Cxcl12.
Similarly, VEGF-A164 strongly enhanced ephrinB2 expression in
both Cxcr4+ and Cxcr4 endothelial cells (Figures 5D and 5F).
However, Cxcl12 did not upregulate ephrinB2 expression in
Cxcr4+ endothelial cells (Figure 5D).
These data indicate that Cxcl12-Cxcr4 signaling does not
induce arterial differentiation. To further examine whether
Cxcl12-Cxcr4 signaling is required for responsiveness to
VEGF-A in endothelial cells, we isolated ephrinB2, PECAM-1+
endothelial cells from Cxcr4/ mutant embryos using anti-
ephrinB2 antibody and cultured the cells in the presence of
VEGF-A164. VEGF-A164 can induce ephrinB2 expression in
Cxcr4-deficient endothelial cells (Figure S5). These data indicate
that Cxcl12-Cxcr4 signaling is not responsible for responsive-Developmness to VEGF-A in arterial differentiation. We next examined
whether deficient Cxcl12-Cxcr4 signaling somehow leads to
impaired VEGF-A expression in the nerves. There was no signif-
icant difference in VEGF-A expression between Cxcl12/
mutants and control littermates (Figures 5H versus 5I and 5J
versus 5K, arrows), indicating that defective arterial differentia-
tion in Cxcl12/ or Cxcr4/ mutants is not caused by the
reduction of nerve-derived VEGF-A. Considering our previous
observation of defective arteriogenesis in mouse mutants lack-
ing Vegf-a in nerves, VEGF-A signaling is central to arteriogene-
sis (Mukouyama et al., 2005). These observations raised the
interesting possibility that nerve-derived Cxcl12 directs nerve-
vessel association, and only nerve-associated vessels undergo
arteriogenesis via nerve-derived VEGF-A. In this scenario, the
loss of Cxcl12-Cxcr4 signaling may perturb arterial differentia-
tion of small-diameter vessels due to their lack of close proximity
to the nerves.
Nerve-Derived Cxcl12 Stimulates Endothelial Cell
Migration via Cxcr4
The foregoing experiments indicated that although loss of
Cxcl12-Cxcr4 signaling caused a failure of nerve-vessel align-
ment, it was not directly involved in arterial differentiation.
Because endothelial cell migration may be critical during the
alignment process, we next examined whether a peripheral
nerve-derived signal(s) induces endothelial cell migration
in vitro. To do so, we employed a modified transwell assay using
MSS31 cells, a mouse endothelial cell line in which cell-surface
Cxcr4 expression was detected by flow cytometry (data not
shown) and VEGF-A164 can enhance arterial differentiation in
culture (Figure S6). DRG were dissociated from E13.5 embryos
and cultured for 1 week to produce DRG-conditioned medium
(Figure 6A). The DRG-conditioned medium was then added to
the bottom wells of a multiwell chamber (Figure 6A). MSS31
endothelial cells were added to the upper wells separated from
the lower ones by a fibronectin-coated 8 mmporous polycarbon-
ate membrane filter (Figure 6A). Compared to the basic growth
medium, we observed that DRG-conditioned medium could
induce the migration of MSS31 endothelial cells (Figure 6B).
We next examined whether Cxcl12 could induce endothelial
cell migration. Interestingly, induction of migration was observed
by recombinant Cxcl12 at 300 ng/ml, and the observed effect of
Cxcl12 was nearly as strong as that of the DRG-conditioned
medium (Figure 6B). Importantly, the migration of endothelial
cells elicited by the DRG-conditioned medium was abolished
by treating the cells with either anti-Cxcr4 blocking antibody or
AMD3100, a selective antagonist for Cxcr4 (Figure 6B; Hatse
et al., 2002). Accordingly, the conditioned medium from Cxcl12
knockdown DRG (Figure 6C) failed to induce the migration of
endothelial cells (Figure 6D). Although VEGF-A164 stimulates
the migration of endothelial cells (Figure 6F, left), VEGF-A164 is
not responsible for the chemotactic effect of DRG-conditioned
medium on endothelial cell migration (Figure 6F, right). These
data strongly suggest that Cxcl12-Cxcr4 signaling mediates
the chemotactic effect of DRG-conditionedmedium on endothe-
lial cell migration.
Cxcr4 is a seven-pass transmembrane GPCR, which is
coupled with pertussis toxin (PTX)-sensitive heterotrimeric G
proteins of the Gi family (reviewed in Dorsam and Gutkind,ental Cell 24, 359–371, February 25, 2013 ª2013 Elsevier Inc. 363
Figure 3. Defective Arterial Differentiation and Smooth Muscle Coverage in Cxcl12 and Cxcr4 Homozygous Mutants
Whole-mount triple immunofluorescence labeling of limb skin with antibodies to arterial markers Nrp1 (A–F, red, arrowheads) or Cx40 (H–M, red, arrowheads) and
the smooth muscle cell marker aSMA (O–T, red, arrowheads), in addition to PECAM-1 (A–C, H–J, and O–Q, blue) and neurofilament (2H3) (A–C, H–J, and O–Q,
green, open arrows) inCxcl12/ (B, E, I, L, P, and S),Cxcr4/ (C, F, J, M, Q, and T), or control littermates (A, D, H, K, O, and R) at E15.5 is shown. The expression
of arterial markers such as Nrp1 and Cx40 was conspicuously reduced in remodeled vessels of both Cxcl12/ and Cxcr4/ mutants (B, C, E, and F for Nrp1
(legend continued on next page)
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Figure 4. Requirement for Endothelial Cxcr4
for Patterns of Vascular Branching and Arte-
riogenesis
Whole-mount triple immunofluorescence labeling
of limb skin with antibodies to the arterial marker
Nrp1 (A–D, red, arrowheads) and the smooth
muscle cell marker aSMA (F–I, red, arrowheads), in
addition to PECAM-1 (A, B, F, and G, blue) and
neurofilament (2H3) (A, B, F, and G, green, open
arrows) in Tie2-Cre; Cxcr4flox/ and control litter-
mates is shown. Compared to control littermates,
disrupted nerve-vessel alignment was observed in
Tie2-Cre; Cxcr4flox/ mutants (A versus B, arrow-
heads and open arrows). The expression of Nrp1
was nearly abolished in Tie2-Cre; Cxcr4flox/
mutants (D, arrowheads). aSMA+ smooth muscle
cell coverage was strongly reduced in small-
diameter branched vessels in Tie2-Cre; Cxcr4flox/
mutants (F versus G, and H versus I, arrowheads),
although smooth muscle coverage in large-diam-
eter veins appeared unaffected (F versus G, and H
versus I). Overall, Tie2-Cre; Cxcr4flox/ mutants
exhibit an almost identical phenotype toCxcl12/
orCxcr4/mutants. Scale bars represent 100 mm.
Quantification of Nrp1 expression (E) or aSMA+
smooth muscle cell coverage (J) in small-diameter
branched vessels was performed (n = 3 per
genotype; bars represent mean ± SEM).
Asterisk indicates statistically significant differ-
ence (p < 0.05) in mutants compared with control
littermates according to Student’s t test. See also
Figures S2 and S4.
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endothelial cells was sensitive to PTX treatment. Indeed, treat-
ment of MSS31 endothelial cells with PTX resulted in a dramatic
inhibition of the migratory response toward both DRG-condi-
tioned medium and Cxcl12 (Figure 6E). These data suggest
that Gi protein-mediated Cxcr4 signaling is central to endothelial
cell migration stimulated by DRG-conditioned medium.
These findings reveal that during the nerve-vessel align-
ment process, nerve-derived Cxcl12 instructs the migration of
Cxcr4+ endothelial cells to form nerve-associated vessels.
Cxcl12-Cxcr4 signaling functions as a long-range chemotactic
guidance cue to recruit vessels to align with nerves. Subse-
quently, nerve-derived VEGF-A instructs arterial differentiation
in the nerve-associated vessels. Arterial differentiation presum-expression; I, J, L, and M for Cx40 expression, arrowheads). Note that weak Nrp1 expression can be dete
proximity to nerves in Cxcl12/ (B and E, open arrowheads) and Cxcr4/mutants (C and F, open arrowhea
with small-diameter branched vessels in Cxcl12/ and Cxcr4/ mutants (O versus P and Q, and R versu
coverage in large-diameter veins appeared unaffected (S and T, open arrowheads). Scale bars represent 1
(G and N) or aSMA+ smooth muscle cell coverage (U) in small-diameter branched vessels was performed
Asterisk indicates statistically significant difference (p < 0.05) in both mutants compared with control litterm
Developmental Cell 24, 359–371,ably requires a local action of VEGF-A
to induce arterial marker expression
(Figure 7).
DISCUSSION
Patterning of blood vessel branching is
complex and variable, but it is not at allrandom. In the limb skin, arterial branching is precisely controlled
by the branching pattern of peripheral nerves. Nerves provide
signals that determine both the pattern of blood vessel branch-
ing and arterial differentiation. Our previous studies demon-
strated that nerve-derived VEGF-A controls arterial differentia-
tion but not nerve-vessel alignment (Mukouyama et al., 2002,
2005). This highlighted the undetermined nature of the nerve-
derived signal that controls the vascular branching pattern
during the alignment process. In this study, we have found that
nerve-vessel alignment depends on the activity of a GPCR
signaling pathway that is mediated by nerve-derived ligand
Cxcl12 and its endothelial cell receptor, Cxcr4. Genetic inactiva-
tion of Cxcl12-Cxcr4 signaling perturbs nerve-vessel alignment
and abolishes arteriogenesis. Further in vitro assays allowed uscted in some remodeled vessels in relatively close
ds). Fewer aSMA+ smooth muscle cells associated
s S and T, arrowheads), although smooth muscle
00 mm. Quantification of arterial marker expression
(n = 4 per genotype; bars represent mean ± SEM).
ates according to Student’s t test.
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Chemokine Signal Regulates Nerve-Vessel Alignmentto uncouple nerve-vessel alignment and arteriogenesis, re-
vealing that nerve-derived Cxcl12 recruits vessels to nerves
and that nerve-derived VEGF-A induces arterial differentiation.
Our findings, therefore, have revealed a sequential mechanism
underlying nerve-mediated patterning and the differentiation
processes of endothelial cells.
Cxcl12 as the Nerve-Mediated Vascular Patterning
Signal
Our results support the conclusion that Cxcl12-Cxcr4 signaling
controls nerve-mediated arterial branching in developing limb
skin. Peripheral nerves express Cxcl12, whereas its receptor
Cxcr4 is expressed by a subset of endothelial cells in capillary
vessels adjacent to nerves prior to vascular remodeling, and
subsequently the expression is restricted to larger nerve-associ-
ated arteries. Nerve- or Schwann cell-derived Cxcl12 seems
diffusible because it can influence endothelial cells in neigh-
boring capillary vessels. Our previous genetic studies provided
evidence that Schwann cells produce local signals that control
nerve-vessel alignment and arterial differentiation. The loss of
erbB3 receptor signaling in vivo results in the complete absence
of peripheral nerve-associated Schwann cells, and nerve-vessel
alignment and arterial marker expression are greatly reduced
(Mukouyama et al., 2002). Because erbB3 expression is not
detectable in skin endothelial cells, the vascular defects are likely
due to the absence of Schwann cells. To confirm whether
Schwann cell-derived Cxcl12 controls nerve-vessel association
in vivo, a Schwann cell-specific knockout of Cxcl12 would be
required.
Our results imply that nerve-derived Cxcl12 triggers themigra-
tion of Cxcr4+ endothelial cells, acting as the nerve-derived che-
moattractant signal. Once the Cxcr4+ cells are recruited to the
nerve, nerve-derived VEGF-A, but not Cxcl12, influences the
cells to induce arterial differentiation. Based on these results,
we propose a model in which these two mechanisms underlie
endothelial cell patterning and arterial differentiation during the
vascular remodeling, resulting in the formation of nerve-artery
alignment (Figure 7). Because Cxcl12 and VEGF-A are secreted
by nerves, the question arises as to how capillary endothelial
cells respond to these factors. Perhaps Cxcl12 functions as
a long-range chemotactic guidance cue for endothelial cells as
shown in other cellular systems: lymphocyte recruitment at sites
of immune and inflammatory reactions, primordial germ cell
migration, and metastatic migration of breast cancer cells
toward Cxcl12-expressing organs such as lung, liver, and bone
marrow (reviewed in Raz and Mahabaleshwar, 2009). On the
other hand, arterial differentiation presumably requires localFigure 5. Cxcl12 Cannot Induce Arterial Differentiation In Vitro
(A) Schematic illustrating the experimental procedure for endothelial cell isolatio
tiation assay in culture.
(B–G) PECAM-1+/ephrinB2 (B and C), PECAM-1+/ephrinB2/CXCR4+ (D and E),
10 ng/ml VEGF-A, 500 ng/ml Cxcl12, or both proteins plus 10 ng/ml bFGF for 2 d
that VEGF-A induced ephrinB2 expression in 45% of FACS-purified endotheli
Cxcl12 by itself did not upregulate ephrinB2 expression and showed no synergis
observed under these conditions in the Cxcr4+ subpopulation of endothelial ce
mean ± SEM). Asterisk indicates statistically significant difference (p < 0.05) acc
(H–K) Whole-mount immunohistochemical analysis of limb skin with antibodies
significant difference in VEGF-A expression between Cxcl12/ mutants (I and K
See also Figure S5.
Developmaction of VEGF-A in endothelial cells in close proximity to nerves.
VEGF-A is secreted as multiple isoforms, which differ in their
affinity for heparin in the extracellular matrix. In addition, the
VEGF-A coreceptor Nrp1 is preferentially expressed in arterial
endothelial cells (Mukouyama et al., 2002, 2005), and is selective
for the heparin-binding isoforms (e.g., VEGF164) of VEGF-A.
Previous studies demonstrated that Nrp1 is required to amplify
the VEGF-A effect during arterial differentiation (Mukouyama
et al., 2005). Although sensory neurons and glia contribute to
the expression of multiple VEGF-A isoforms, nerve-associated
endothelial cells might potentially be exposed to higher levels
of Nrp1-binding VEGF-A.
Cxcr4 Is the Major Receptor for Cxcl12-Mediated
Nerve-Vessel Alignment
The present loss-of-function data indicating that Cxcl12/
mutants exhibit an almost identical phenotype to the Cxcr4/
mutation suggest that ligand-receptor interactions between
Cxcl12 and Cxcr4 are essential for neurovascular associations
in the skin. Given that another high-affinity receptor, Cxcr7, is
involved in cardiac valve development in mice (Gerrits et al.,
2008; Sierro et al., 2007; Yu et al., 2011) and Cxcr4-mediated
migration of primordial germ cell and posterior lateral line primor-
dium in zebrafish (reviewed in Raz and Mahabaleshwar, 2009),
the slight reduction of nerve-vessel alignment seen in Cxcr7
mutants might be caused by the lack of Cxcr7-mediated fine-
tuning of Cxcr4 activation or a Cxcl12 gradient. However, the
attenuation has no impact on arterial differentiation. These
data suggest that Cxcl12-Cxcr4 signaling is the predominant
functional signaling pathway in this system.
Our extensive immunohistochemical analysis of Cxcr4 ex-
pression in developing limb skin vasculature reveals that
Cxcr4 is expressed by a subset of endothelial cells (16.5% of
PECAM-1+ endothelial cells are positive for Cxcr4) in capillary
vessels before nerve-vessel alignment occurs, and subse-
quently the expression becomes restricted to nerve-associated
arteries. Recent studies indicate that Cxcr4 is expressed by
actively sprouting endothelial cells known as tip cells in retina
vasculature in the mouse (Strasser et al., 2010). This implies
that endothelial Cxcr4 expression in capillary vessels may repre-
sent an active phase of cell migration, although no typical tip cell
structure is detectable in limb skin capillaries (W.L. and Y.M.
unpublished data).
This selective expression of Cxcr4 poses the question of
whether Cxcr4+ endothelial cells are prespecified to undergo
arterial differentiation. Our RT-PCR experiments indicate that
the expression of markers of arterial and venous identity doesn from E11.5 ephrinB2taulacZ/+ heterozygous embryos and the arterial differen-
or PECAM1+/ephrinB2/CXCR4 (F and G) endothelial cells were cultured in
ays, followed by double staining with X-gal and anti-PECAM-1 antibody. Note
al cells without a change in the total number of endothelial cells. By contrast,
tic effect with VEGF-A. Furthermore, no increase of ephrinB2 expression was
lls. Statistical analysis is from three independent experiments (bars represent
ording to Student’s t test.
to VEGF (red, arrows) and bIII tubulin (Tuj1, green) is shown. There was no
) and control littermates (H and J). Scale bars represent 100 mm.
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Figure 6. Purified DRG Sensory Neurons and Schwann Cells Promote Endothelial Cell Migration In Vitro via Cxcl12-Cxcr4 Signaling
(A) Schematic illustrating the experimental procedure for DRG dissection from E13.5 embryos and the chemotaxis assay.
(B) DRG culture supernatant stimulated migration of Cxcr4+ MSS31 endothelial cells, and this effect was blocked by treatment with either anti-Cxcr4 blocking
antibody (R&D Systems) or AMD3100, a selective antagonist for Cxcr4. Cxcl12 (300 ng/ml) stimulatedmigration of MSS31 endothelial cells at a level similar to the
DRG culture supernatant. Statistical analysis is from three independent experiments (bars represent mean ± SEM). Asterisk indicates statistically significant
induction of migration of MSS31 endothelial cells (p < 0.01) after treatment with Cxcl12 or the DRG culture supernatant, and a statistically significant inhibition of
DRG supernatant stimulated migration of MSS31 endothelial cells (p < 0.01) after treatment with anti-Cxcr4 blocking antibody or AMD3100, according to
Student’s t test.
(C and D) The supernatant from Cxcl12 knockdown DRG culture failed to induce migration of MSS31 endothelial cells. DRGs were infected with a control or
Cxcl12 shRNA lentivirus. The expression levels ofCxcl12were assessed by RT-PCR analysis (C). Compared to the supernatant from control shRNA-treated DRG
culture, the supernatant from the Cxcl12 knockdown DRG culture failed to induce migration of MSS31 endothelial cells. Statistical analysis is from three
independent experiments (bars represent mean ± SEM). Asterisk indicates statistically significant induction ofmigration ofMSS31 endothelial cells (p < 0.01) after
treatment with the supernatant from control shRNA-treated DRG culture, and a statistically significant reduction of migration of MSS31 endothelial cells (p < 0.01)
after treatment with the supernatant from Cxcl12 knockdown DRG culture, according to Student’s t test.
(E) The effect on endothelial cell migration induced by the DRG culture supernatant or 300 ng/ml Cxcl12 was blocked by treatment with 2 ng/ml pertussis toxin,
a G protein inhibitor. Statistical analysis is from three independent experiments (bars represent mean ± SEM). Asterisk indicates statistically significant difference
(p < 0.01) according to Student’s t test.
(F) VEGF-A is not responsible for the effect onendothelial cellmigration inducedby theDRGculture supernatant. VEGF-A (10ng/ml) stimulatedmigrationofMSS31
endothelial cells, and this effect was blocked by treatment with 100 ng/ml soluble Flt1-Fc (VEGFR1-Fc) protein. Soluble Flt1-Fc protein (100 ng/ml) failed to block
DRG supernatant-stimulatedmigration of MSS31 endothelial cells. Statistical analysis is from three independent experiments (bars represent mean ± SEM). Left:
asterisk indicates statistically significant induction ofmigration ofMSS31 endothelial cells (p < 0.05) induced by treatmentwith VEGF-A, and statistically significant
inhibition of VEGF-A stimulated migration of MSS31 endothelial cells (p < 0.05) after treatment with soluble Flt1-Fc protein compared to control Fc protein,
according to Student’s t test. Right: asterisk indicates statistically significant induction ofmigration ofMSS31 endothelial cells (p < 0.05) induced by treatment with
the DRG culture supernatant with or without control Fc protein or soluble Flt1-Fc protein compared to basic medium, according to Student’s t test.
See also Figure S6.
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thelial cells (Figures S1C and S1D). These data suggest that
Cxcr4+ endothelial cells may not initially be biased toward an368 Developmental Cell 24, 359–371, February 25, 2013 ª2013 Elsevarterial fate. If Cxcr4+ endothelial cells are committed to arterial
fate but have not yet differentiated, then these cells would be
fully responsive to VEGF-A in our in vitro arterial differentiationier Inc.
Figure 7. Coordinate Action of Nerve-Derived Cxcl12 and VEGF-A Results in Nerve-Artery Alignment
(A) Schematic model for nerve-mediated vascular branching and arterial differentiation in developing limb skin. Sensory nerves invade at approximately
E11.5E13.5, after a primary capillary plexus is established. Subsequently, the pattern of sensory nerves provides signals (Cxcl12 and VEGF-A) that govern
patterns of vascular branching and arterial differentiation during vascular remodeling. As a result, the congruence of blood vessel and nerve patterns is
established in the skin.
(B) This scheme shows how nerve-derived Cxcl12 and VEGF-A control patterns of vascular branching and arterial differentiation. In this view, oxygen-starved
nerves may induce Cxcl12 and VEGF-A expression through activation of HIF-1 prior to vascular remodeling. Cxcl12-Cxcr4 signaling functions as a long-range
chemotactic guidance cue to recruit vessels to align with nerves. Nerve-derived VEGF-A instructs arterial differentiation in the nerve-associated vessels. Arterial
differentiation presumably requires a local action of VEGF-A to induce arterial marker expression.
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underwent arterial differentiation, and there appeared to be no
significant difference in the effect of VEGF-A between Cxcr4+
and Cxcr4 endothelial cells. Taken together, we cannot pres-
ently discern whether Cxcr4 expression in capillary endothelial
cells is correlated with commitment to an arterial fate.
Cxcl12 and VEGF-A as Hypoxia-Inducible Genes
How are the expression of Cxcl12 and VEGF-A coordinated in
nerves? One scenario is that oxygen-starved nerves produce
local signals that govern the precise pattern of arterial branching
along the nerves during angiogenic remodeling. In support of
this, it has been reported that hypoxia induces Cxcl12 and
VEGF-A expression through activation of the transcription factor
hypoxia-inducible factor 1 (HIF-1) (Ceradini et al., 2004; Forsythe
et al., 1996; Shweiki et al., 1992). Previous studies have indicated
that the induction of VEGF-A and Cxcl12 in response to hypoxia/
ischemia promotes neovascularization with tumor progression
(Plate et al., 1992) and tissue regeneration (Ceradini et al.,Developm2004), suggesting that expression of these signals is common.
Local hypoxia may trigger Cxcl12 and VEGF-A expression in
the nerves, directing arterial branching along the nerves during
vascular remodeling. Because the regulatory regions of Cxcl12
and Vegf-a genes contain a HIF-dependent hypoxia-responsive
enhancer, a direct test of this scenario will require nerve-specific
knockouts of Hif-1.
Organ-Specific Vascular Patterning
Blood flow is critical for the processes in which a primary
capillary plexus undergoes extensive vascular remodeling and
develops into a hierarchical branched, vascular network (Culver
and Dickinson, 2010). However, hemodynamic force alone is not
sufficient to establish a highly stereotypical vascular branching
pattern or determine arterial and/or venous fate in an organ-
specific manner. As such, the embryonic limb skin vasculature
model has proven to be useful for studying how organ-specific
local signals provided by organized components, such as
nerves, coordinate vascular remodeling and the formation ofental Cell 24, 359–371, February 25, 2013 ª2013 Elsevier Inc. 369
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lying endothelial cell migration induced by Cxcl12 and arterial
differentiation induced by VEGF-A act in concert, resulting
in nerve-artery alignment. Similar coordinated action may
be observed in various organs, where different components




The characterization ofCxcl12/mice (Nagasawa et al., 1996),Cxcr4/mice
(Tachibana et al., 1998),Cxcl12GFP/+ knockin mice (Ara et al., 2003),Cxcr4flox/
mice (Tokoyoda et al., 2004), Tie2-Cre mice (Ara et al., 2005; Kisanuki et al.,
2001), ephrinB2taulacZ/+ mice (Wang et al., 1998), and Sema3A/ mice (Tani-
guchi et al., 1997) have been reported elsewhere. Conventional Cxcr7
knockout mice were generated at the Zou laboratory by homologous recom-
bination in ES cells according to standard procedures. All animals and proce-
dures for mouse experiments were approved by the National Heart, Lung, and
Blood Institute Animal Care and Use Committee.
RT-PCR
Quantitative mRNA expression analysis of chemokines and their receptors in
E13.5 DRG and forelimb skins was performed with the mouse chemokine
and receptor RT2 profiler PCR array (QIAGEN) on 7500 Real Time PCR
systems (Applied Biosystems) using RT2 SYBR Green qPCR master mix (-
QIAGEN). A detailed description of experiments and the sequence of the
PCR primers are described in Supplemental Experimental Procedures.
Whole-Mount Immunohistochemistry of Limb Skin
Staining was performed essentially as described previously (Mukouyama
et al., 2002; Li and Mukouyama, 2011). All confocal microscopy was carried
out on a Leica TCS SP5 confocal microscope. The averagemean fluorescence
(pixel/area) and nerve length were analyzed using ImageJ software (National
Institutes of Health). Vascular density (volume of vessels per mm3) was
analyzed using Volocity software (PerkinElmer). The number of embryos is
indicated as ‘‘n’’ in the figure legends. The statistical significance of samples
was assessed using Student’s t test. Details of the procedure are available
in Supplemental Experimental Procedures.
Section Immunohistochemistry
Section staining was performed as described previously (Mukouyama et al.,
2005). All confocal microscopy was carried out on a Leica TCS SP5 confocal
microscope. H&E staining of sections was performed and images were
captured using a QImaging Retiga-2000R camera. Details of the procedure
are available in Supplemental Experimental Procedures.
Flow Cytometry and Culture Methods
Forelimb skins were peeled off from E13.5 and E15.5 embryos and dissociated
by digestion with 1 mg/ml type I collagenase (Worthington), 3 mg/ml dispase
(GIBCO/Invitrogen), and 0.5 mg/ml DNase 1 (Sigma). The dissociated cells
were then stained with phycoerythrin-conjugated anti-PECAM-1 antibody
(1:50, 30 min on ice; BD Pharmingen) and/or allophycocyanin-conjugated
anti-Cxcr4 antibody (1:50, 30 min on ice; BD Pharmingen). The PECAM-1+,
Cxcr4+ population was sorted into TRIzol reagent (Invitrogen) for total RNA
preparation. All cell sorts and analyses were performed on a MoFlo (Beckman
Coulter). Details of the procedure for the isolation and culture of ephrinB2-
negative, ephrinB2-negative Cxcr4-positive, or ephrinB2-negative Cxcr4-
negative endothelial cells from E11.5 ephrinB2lacZ/+ embryos are available in
Supplemental Experimental Procedures.
DRG Isolation and Culture Methods
DRG were isolated from E13.5 embryos as previously described (Mukouyama
et al., 2002). Briefly, DRG were dissociated by digestion with a Papain Disso-
ciation System (Worthington). Culture medium contained EGM-2 MV (Lonza)
with SingleQuot supplement (Lonza). The freshly isolated cells were cultured
or infected by CXCL12 shRNA lentivirus (3 transduction units/cell; Sigma)370 Developmental Cell 24, 359–371, February 25, 2013 ª2013 Elsevwith 25 ng/ml nerve growth factor (UBI) on fibronectin (Biomedical Technolo-
gies)-coated dishes for 7 days, and the supernatant was passed through
a 0.45 mm filter after centrifugation.
Chemotactic Migration Assay
Chemotactic migration assay was performed with a 48-well modified Boyden
chamber (Neuro Probe) using a polycarbonate membrane with an 8 mm pore
size. Details of the procedure are available in Supplemental Experimental
Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and Supplemental Experimental
Procedures and can be found with this article online at http://dx.doi.org/
10.1016/j.devcel.2013.01.009.
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